Metrovacesa S.A. (BME:MVC)
11.02
-0.16 (-1.43%)
Jun 23, 2026, 5:35 PM CET
Metrovacesa Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Metrovacesa stock has a consensus rating of "Hold" and an average price target of €11.28. The average 1-year stock price forecast is 2.36% higher than the current stock price, while the lowest is €9.30 (-15.61%) and the highest is €12.70 (+15.25%).
Price Target: €11.28 (+2.36%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Metrovacesa stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 2 | 2 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 4 | 4 |
Financial Forecast
Revenue This Year
745.00M
from 708.37M
Increased by 5.17%
Revenue Next Year
779.50M
from 745.00M
Increased by 4.63%
EPS This Year
0.46
from 0.57
Decreased by -20.57%
EPS Next Year
0.44
from 0.46
Decreased by -3.30%
EPS based on non-GAAP adjusted numbers. Financial currency is EUR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 766.0M | ||
| Avg | 745.0M | ||
| Low | 724.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.1% | ||
| Avg | 5.2% | ||
| Low | 2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.48 | ||
| Avg | 0.46 | ||
| Low | 0.43 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -16.2% | ||
| Avg | -20.6% | ||
| Low | -24.9% |